M&A
confidence high
sentiment positive
materiality 0.75
Odyssey Health shareholders approve asset sale to Oragenics for $1M cash + 8M shares
Odyssey Health, Inc.
- Stockholders voted 45,032,700 for, 382,191 against the asset sale to Oragenics.
- $1M total cash consideration: $500k paid on signing, second $500k paid after shareholder approval on Dec 11.
- Upon closing, Odyssey will receive 8M shares of Oragenics Convertible Preferred Class F stock (1:1 conversion to common).
- Transaction expected to close before end of 2023.